Back
Haemonetics Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
51
HAE
Haemonetics
Last Price:
73.54
Seasonality Move:
3.68%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Haemonetics Price Quote
$73.54
+0.01 (+2.88%)
(Updated: November 5, 2024 at 3:18 AM ET)
Haemonetics Key Stats
Buy
51
Haemonetics (HAE)
is a Buy
Day range:
$71.43 - $73.67
52-week range:
$70.25 - $97.97
Dividend yield:
0%
P/E ratio:
32.11
P/S ratio:
2.84
P/B ratio:
4.16%
Volume:
607.9K
Avg. volume:
525.4K
1-year change:
-16.85%
Market cap:
$3.8B
Revenue:
$1.3B
EPS:
$2.23
How Much Does Haemonetics Make?
-
How Much Are Haemonetics's Sales Annually?
HAE Revenues are $1.3B -
How Much Profit Does Haemonetics's Make A Year?
HAE net income is $117.6M
Is Haemonetics Growing As A Company?
-
What Is Haemonetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Haemonetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.08%
Haemonetics Stock Price Performance
-
Did Haemonetics Stock Go Up Last Month?
Haemonetics share price went down by -5.6% last month -
Did HAE's Share Price Rise Over The Last Year?
HAE share price fell by -16.85% over the past 1 year
What Is Haemonetics 52-Week High & Low?
-
What Is Haemonetics’s 52-Week High Share Price?
Haemonetics has traded as high as $97.97 over the past 52 weeks -
What Is Haemonetics’s 52-Week Low Share Price?
Haemonetics has traded as low as $70.25 over the past 52 weeks
Haemonetics Price To Free Cash Flow
-
Is Haemonetics Stock Overvalued?
Haemonetics is trading at a price to free cash flow ratio of 53.31 -
Is Haemonetics Stock Undervalued?
Haemonetics EV to Free Cash Flow ratio is 65.41 -
What Is Haemonetics’s Price Earnings Growth Ratio?
HAE PEG ratio is 0.00 -
Is Haemonetics Trading At A Premium To Earnings?
Haemonetics EV to EBIT ratio is 30.75
Is It Risky To Buy Haemonetics?
-
How Much Debt Does Haemonetics Have?
Total long term debt quarterly is $1.2B -
How Much Cash Does Haemonetics Have?
Cash and short term investments quarterly total is $344.4M -
What Is Haemonetics’s Book Value Per Share?
Book value per share is 17.70
Is Haemonetics Cash Flow Positive?
-
What Is HAE Cash Flow From Operations?
Cash flow from operations (TTM) is $135.2M -
What Is Haemonetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $372.4M -
What Is Haemonetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$446.3M
Haemonetics Return On Invested Capital
-
Is Management Doing A Good Job?
HAE return on invested capital is 6.39% -
What Is Haemonetics Return On Assets?
ROA measures how assets are converting to revenues and is 5.27% -
What Is HAE Return On Equity?
ROE is a measure of profitability and is 12.58%
Haemonetics Earnings Date & Stock Price
-
What Is Haemonetics's Stock Price Today?
A single share of HAE can be purchased today for 73.53 -
What Is Haemonetics’s Stock Symbol?
Haemonetics trades on the nyse under the ticker symbol: HAE -
When Is Haemonetics’s Next Earnings Date?
The next quarterly earnings date for Haemonetics is scheduled on November 7, 2024 -
When Is HAE's next ex-dividend date?
Haemonetics's next ex-dividend date is November 5, 2024 -
How To Buy Haemonetics Stock?
You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Haemonetics Competitors
-
Who Are Haemonetics's Competitors?
Below is a list of companies who compete with Haemonetics or are related in some way:
Haemonetics Dividend Yield
-
What Is HAE Dividend Yield?
Haemonetics’s dividend yield currently is 0% -
What Is Haemonetics’s Payout Ratio?
Haemonetics’s payout ratio is 0% -
When Did Haemonetics Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Haemonetics’s Dividend Per Share?
Haemonetics pays a dividend of $0.00 per share
Haemonetics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -7.5% | 1.44% |
| Revenue: | 7.98% | 0.34% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 109.80 |
| Upside from Last Price: | 49.33% |